JKHY:NASDAQJack Henry & Associates, Inc. Analysis
Data as of 2026-03-13 - not real-time
$168.77
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Jack Henry & Associates (JKHY) is trading just below its 50‑day moving average and near a key resistance level, while comfortably staying above the 20‑day SMA, indicating short‑term price stability. The RSI hovers around the neutral 50 mark and the MACD histogram is positive, supporting a modest bullish bias. Recent analyst sentiment has turned more favorable, highlighted by Wells Fargo upgrading the stock to Overweight and raising its price target, and the company announcing a dividend increase, which reinforces the appeal of its modest yield. Fundamentally, the firm delivers solid revenue growth, healthy operating margins and a strong ROE, with a payout ratio that leaves ample room for dividend sustainability. However, the market price is well above the discounted cash‑flow fair‑value estimate, suggesting the stock may be stretched in the near term. Volume trends are easing, and volatility remains elevated, underscoring the need for disciplined positioning.
Overall, the blend of steady earnings, a supportive dividend, and a favorable upgrade creates a compelling medium‑ to long‑term case, while the proximity to resistance and overvaluation caution against aggressive short‑term buying.
Overall, the blend of steady earnings, a supportive dividend, and a favorable upgrade creates a compelling medium‑ to long‑term case, while the proximity to resistance and overvaluation caution against aggressive short‑term buying.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical resistance
- Neutral trend and decreasing volume
- Recent upgrade but overvaluation concerns
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Consistent revenue growth and strong margins
- Dividend increase and sustainable payout
- Wells Fargo overweight rating and higher target price
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust ROE and cash‑flow generation
- Strategic position in fintech services for banks and credit unions
- Potential for continued earnings expansion despite current premium
Key Metrics & Analysis
Financial Health
Revenue Growth7.90%
Profit Margin20.59%
P/E Ratio24.2
ROE24.28%
ROA13.35%
Debt/Equity3.11
P/B Ratio5.5
Op. Cash Flow$708.2M
Free Cash Flow$335.3M
Industry P/E33.7
Technical Analysis
TrendNeutral
RSI51.3
Support$154.76
Resistance$172.84
MA 20$163.56
MA 50$173.94
MA 200$169.73
MACDBullish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair Value$87.59
Target Price$203.21
Upside/Downside20.41%
GradeOvervalued
TypeBlend
Dividend Yield1.41%
Risk Assessment
Beta0.41
Volatility37.82%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.